These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 18836649)

  • 1. [Anticoagulation in pulmonary arterial hypertension].
    Grünig E; Ehlken N; Nagel Ch
    Hamostaseologie; 2008 Oct; 28(4):225-30. PubMed ID: 18836649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Anticoagulation therapy in pulmonary arterial hypertension].
    Akagi S; Kusano KF
    Nihon Rinsho; 2008 Nov; 66(11):2174-8. PubMed ID: 19051739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coagulation and anticoagulation in pulmonary arterial hypertension.
    Berger G; Azzam ZS; Hoffman R; Yigla M
    Isr Med Assoc J; 2009 Jun; 11(6):376-9. PubMed ID: 19697592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathophysiological basis for anticoagulant and antithrombotic therapy in pulmonary hypertension.
    Lopes AA
    Cardiovasc Hematol Agents Med Chem; 2006 Jan; 4(1):53-9. PubMed ID: 16529549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble CD40 ligand in pulmonary arterial hypertension: possible pathogenic role of the interaction between platelets and endothelial cells.
    Damås JK; Otterdal K; Yndestad A; Aass H; Solum NO; Frøland SS; Simonsen S; Aukrust P; Andreassen AK
    Circulation; 2004 Aug; 110(8):999-1005. PubMed ID: 15302794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pulmonary arterial hypertension].
    Jaïs X; Sitbon O; Savale L; Montani D; Humbert M; Simonneau G
    Rev Prat; 2008 Nov; 58(18):1997-2010. PubMed ID: 19143271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Warfarin in systemic sclerosis-associated and idiopathic pulmonary arterial hypertension. A Bayesian approach to evaluating treatment for uncommon disease.
    Johnson SR; Granton JT; Tomlinson GA; Grosbein HA; Le T; Lee P; Seary ME; Hawker GA; Feldman BM
    J Rheumatol; 2012 Feb; 39(2):276-85. PubMed ID: 22247353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bleeding events in pulmonary arterial hypertension.
    Opitz CF; Kirch W; Mueller EA; Pittrow D
    Eur J Clin Invest; 2009 Jun; 39 Suppl 2():68-73. PubMed ID: 19335748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of warfarin on survival in scleroderma-associated pulmonary arterial hypertension (SSc-PAH) and idiopathic PAH. Belief elicitation for Bayesian priors.
    Johnson SR; Granton JT; Tomlinson GA; Grosbein HA; Hawker GA; Feldman BM
    J Rheumatol; 2011 Mar; 38(3):462-9. PubMed ID: 21159827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticoagulation in pulmonary arterial hypertension: a qualitative systematic review.
    Johnson SR; Mehta S; Granton JT
    Eur Respir J; 2006 Nov; 28(5):999-1004. PubMed ID: 17074918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticoagulation in Pulmonary Arterial Hypertension.
    Robinson JC; Pugliese SC; Fox DL; Badesch DB
    Curr Hypertens Rep; 2016 Jun; 18(6):47. PubMed ID: 27137522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Warfarin Treatment on Survival of Patients With Pulmonary Arterial Hypertension (PAH) in the Registry to Evaluate Early and Long-Term PAH Disease Management (REVEAL).
    Preston IR; Roberts KE; Miller DP; Sen GP; Selej M; Benton WW; Hill NS; Farber HW
    Circulation; 2015 Dec; 132(25):2403-11. PubMed ID: 26510696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticoagulation and survival in pulmonary arterial hypertension: results from the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA).
    Olsson KM; Delcroix M; Ghofrani HA; Tiede H; Huscher D; Speich R; Grünig E; Staehler G; Rosenkranz S; Halank M; Held M; Lange TJ; Behr J; Klose H; Claussen M; Ewert R; Opitz CF; Vizza CD; Scelsi L; Vonk-Noordegraaf A; Kaemmerer H; Gibbs JS; Coghlan G; Pepke-Zaba J; Schulz U; Gorenflo M; Pittrow D; Hoeper MM
    Circulation; 2014 Jan; 129(1):57-65. PubMed ID: 24081973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombotic arteriopathy and anticoagulation in pulmonary hypertension.
    Johnson SR; Granton JT; Mehta S
    Chest; 2006 Aug; 130(2):545-52. PubMed ID: 16899857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticoagulation in patients with pulmonary arterial hypertension: An update on current knowledge.
    Roldan T; Landzberg MJ; Deicicchi DJ; Atay JK; Waxman AB
    J Heart Lung Transplant; 2016 Feb; 35(2):151-64. PubMed ID: 26527532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary hypertension in thalassemia: association with platelet activation and hypercoagulable state.
    Singer ST; Kuypers FA; Styles L; Vichinsky EP; Foote D; Rosenfeld H
    Am J Hematol; 2006 Sep; 81(9):670-5. PubMed ID: 16795058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The current view on pathophysiology of pulmonary arterial hypertension].
    Cisowska M; Lewczuk J
    Pol Merkur Lekarski; 2007 Apr; 22(130):286-90. PubMed ID: 17684928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C-reactive protein: a new predictor of adverse outcome in pulmonary arterial hypertension.
    Quarck R; Nawrot T; Meyns B; Delcroix M
    J Am Coll Cardiol; 2009 Apr; 53(14):1211-8. PubMed ID: 19341863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical classification and epidemiology of pulmonary arterial hypertension].
    Chaouat A; Gomez E; Canuet M; Weitzenblum E; Chabot F
    Rev Prat; 2008 Nov; 58(18):1991-6. PubMed ID: 19143270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The significance of diminished sTWEAK and P-selectin content in platelets of patients with pulmonary arterial hypertension.
    Kazimierczyk R; Błaszczak P; Kowal K; Jasiewicz M; Knapp M; Szpakowicz A; Ptaszyńska-Kopczyńska K; Sobkowicz B; Waszkiewicz E; Grzywna R; Musial WJ; Kamiński KA
    Cytokine; 2018 Jul; 107():52-58. PubMed ID: 29203267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.